Munafa Stock Market Course + Intraday & FNO calls 
Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arbutus Biopharma (ABUS)
Technical Analysis Report for USA stock ABUS Arbutus Biopharma. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma then click here. or read Experts views on Arbutus Biopharma or Forecast & share price targets of Arbutus Biopharma
Arbutus Biopharma Opened at 4.43 and Closed at: 4.42, which is 0.23% of previous session's close. It moved within a range of 4.31 and 4.45
The session was a Bearish session with an average volume of 730500, which is 29.88% of previous session's volumes.
A Dead cross was found 8 days back on mid term averages
Support for tomorrow is 4.3 and resistance for tomorrow is 4.44
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 4.34, 4.25 resistance for tomorrow's hourly charts is 4.48, 4.53
10 Day SMA for Arbutus Biopharma (ABUS) is 4.34 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Arbutus Biopharma (ABUS) is 4.43 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arbutus Biopharma (ABUS) is 4.44 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 4.09 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Arbutus Biopharma is 3.7 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arbutus Biopharma is at 4.43 and 200 DMA is at 3.7, while 50 DMA and 100 DMA are at 4.44 and 4.09 respectively
Arbutus Biopharma (ABUS) moving average of 20 SMA is at 4.43 and 20 EMA is at 4.39
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 4.42 | 4.43 | 4.39 |
| 04 Thu Dec | 4.41 | 4.43 | 4.39 |
| 03 Wed Dec | 4.43 | 4.44 | 4.39 |
| 02 Tue Dec | 4.17 | 4.44 | 4.39 |
| 01 Mon Dec | 4.21 | 4.47 | 4.41 |
| 28 Fri Nov | 4.41 | 4.5 | 4.43 |
Arbutus Biopharma (ABUS) moving average of 50 SMA is at 4.44 and 50 EMA is at 4.36
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 4.42 | 4.44 | 4.36 |
| 04 Thu Dec | 4.41 | 4.44 | 4.36 |
| 03 Wed Dec | 4.43 | 4.44 | 4.36 |
| 02 Tue Dec | 4.17 | 4.44 | 4.36 |
| 01 Mon Dec | 4.21 | 4.44 | 4.37 |
| 28 Fri Nov | 4.41 | 4.45 | 4.38 |
Arbutus Biopharma (ABUS) moving average of 100 SMA is at 4.09 and 100 EMA is at 4.17
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 4.42 | 4.09 | 4.17 |
| 04 Thu Dec | 4.41 | 4.07 | 4.16 |
| 03 Wed Dec | 4.43 | 4.06 | 4.16 |
| 02 Tue Dec | 4.17 | 4.05 | 4.15 |
| 01 Mon Dec | 4.21 | 4.04 | 4.15 |
| 28 Fri Nov | 4.41 | 4.03 | 4.15 |
Arbutus Biopharma (ABUS) moving average of 200 SMA is at 3.7 and 200 EMA is at 3.99
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 4.42 | 3.7 | 3.99 |
| 04 Thu Dec | 4.41 | 3.69 | 3.99 |
| 03 Wed Dec | 4.43 | 3.69 | 3.99 |
| 02 Tue Dec | 4.17 | 3.68 | 3.99 |
| 01 Mon Dec | 4.21 | 3.68 | 3.99 |
| 28 Fri Nov | 4.41 | 3.67 | 3.99 |
Teladoc Health has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Teladoc Health, about 2.58% more returns!
Penumbra Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Penumbra Inc, about 14.73% more returns!
Prestige Consumer has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Prestige Consumer, about 3.23% more returns!
Arbutus Biopharma has performed better than Cvs Health in short term. Holding Arbutus Biopharma could be a better choice for now!
Charles River has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Charles River, about 11.46% more returns!
Arbutus Biopharma has performed better than Boston Scientific in short term. Holding Arbutus Biopharma could be a better choice for now!
Biohaven Pharmaceutical has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Biohaven Pharmaceutical, about 17.52% more returns!
Tiziana Life has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Tiziana Life, about 1.21% more returns!
Arbutus Biopharma has performed better than Pulse Biosciences in short term. Holding Arbutus Biopharma could be a better choice for now!
Masimo Corporation has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Masimo Corporation, about 0.75% more returns!
Dexcom Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Dexcom Inc, about 20.9% more returns!
Cytokinetics Incorporated has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 10.94% more returns!
Biolinerx has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Biolinerx, about 5.14% more returns!
Atara Biotherapeutics has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Atara Biotherapeutics, about 23.12% more returns!
Arbutus Biopharma has performed better than Atossa Genetics in short term. Holding Arbutus Biopharma could be a better choice for now!
Arbutus Biopharma has performed better than Aptevo Therapeutics in short term. Holding Arbutus Biopharma could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Alnylam Pharmaceuticals, about 5.26% more returns!
Arbutus Biopharma has performed better than Alkermes Plc in short term. Holding Arbutus Biopharma could be a better choice for now!
Arbutus Biopharma has performed better than Acadia Healthcare in short term. Holding Arbutus Biopharma could be a better choice for now!
Arbutus Biopharma Technical analysis of indicators
Price action analysis of Arbutus Biopharma (ABUS) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color Prices appear to be moving up
CCI has generated a SELL signal for Arbutus Biopharma in short term but SELL signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arbutus Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.34 and Arbutus Biopharma ABUS stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma ABUS stock. Volume based technical analysis of Arbutus Biopharma ABUS stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ABUS Experts View which covers a lot of information including buying and selling signals
ABUS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arbutus Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
